The production of IFN can mediate both innate and adaptive immunity through the increase of CD4 and CD8 T lymphocytes and prevent the mobilization of myeloid derived suppressor cells, thereby switching the immune response from immunosuppressive to anti-tumor. This evidence concerns the gene IFNA1 and neoplasm.